These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 12015035
21. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma]. Lu ZQ, Li HG, Xie DR, Zhang HZ, Shen XM, Zeng YJ, Zeng H. Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440 [Abstract] [Full Text] [Related]
22. Anti-angiogenic activity of melatonin in advanced cancer patients. Lissoni P, Rovelli F, Malugani F, Bucovec R, Conti A, Maestroni GJ. Neuro Endocrinol Lett; 2001 Sep; 22(1):45-7. PubMed ID: 11335879 [Abstract] [Full Text] [Related]
23. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma. Zhao J, Hu J, Cai J, Yang X, Yang Z. Chin Med J (Engl); 2003 May; 116(5):772-6. PubMed ID: 12875699 [Abstract] [Full Text] [Related]
24. [Heparanase and vascular endothelial growth factor expression in non-small-cell lung cancer]. Gao X, Liang QZ, Wu XQ, Li SY, Bai HL, Zhang SL, Qi MX, Yuan WY, Wang JW, Wang GB. Zhonghua Jie He He Hu Xi Za Zhi; 2003 Apr; 26(4):210-3. PubMed ID: 12901827 [Abstract] [Full Text] [Related]
25. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node. Saintigny P, Kambouchner M, Ly M, Gomes N, Sainte-Catherine O, Vassy R, Czernichow S, Letoumelin P, Breau JL, Bernaudin JF, Kraemer M. Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546 [Abstract] [Full Text] [Related]
26. Serum angiopoietin-1 as a prognostic marker in resected early stage lung cancer. Park JH, Choi H, Kim YB, Kim YS, Sheen SS, Choi JH, Lee HL, Lee KS, Chung WY, Lee S, Park KJ, Hwang SC, Lee KB, Park KJ. Lung Cancer; 2009 Dec; 66(3):359-64. PubMed ID: 19339077 [Abstract] [Full Text] [Related]
27. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer. Minagawa N, Nakayama Y, Hirata K, Onitsuka K, Inoue Y, Nagata N, Itoh H. Anticancer Res; 2002 Dec; 22(5):2957-63. PubMed ID: 12530025 [Abstract] [Full Text] [Related]
28. [Quantitative study of vascular endothelial growth factor expression in primary lung cancer]. Shi E, Jiang H, Xu S. Zhonghua Yi Xue Za Zhi; 1999 Aug; 79(8):596-8. PubMed ID: 11715407 [Abstract] [Full Text] [Related]
29. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors]. Peng XP, Li JD, Li MD, Ye XM, Yan WC. Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072 [Abstract] [Full Text] [Related]
30. VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cells. Donnem T, Al-Shibli K, Al-Saad S, Delghandi MP, Busund LT, Bremnes RM. Lung Cancer; 2009 Feb; 63(2):277-83. PubMed ID: 18599153 [Abstract] [Full Text] [Related]
31. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. Shang ZJ, Li JR, Li ZB. Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564 [Abstract] [Full Text] [Related]
32. [Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances]. Zhu ZH, Rong TH, Zeng CG, Wu QL, Ma Y, Huang XP, Li BJ, Zhang PY, Zhao JM, Hu W, Zhang SY, Yu H, Ma GW, Zhang LJ, Wen ZS, Fu JH, Long H. Ai Zheng; 2005 Jul; 24(7):865-9. PubMed ID: 16004817 [Abstract] [Full Text] [Related]
33. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen? Lee JK, Hong YJ, Han CJ, Hwang DY, Hong SI. Int J Oncol; 2000 Jul; 17(1):149-52. PubMed ID: 10853032 [Abstract] [Full Text] [Related]
35. Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy. Naumnik W, Izycki T, Swidzińska E, Ossolińiska M, Chyczewska E. Oncol Res; 2007 Jul; 16(9):445-51. PubMed ID: 18074680 [Abstract] [Full Text] [Related]
36. Role of circulating cytokeratin fragments and angiogenic factors in NSCLC patients stage IIIa-IIIb receiving curatively intended treatment. Eriksson P, Brattström D, Hesselius P, Larsson A, Bergström S, Ekman S, Goike H, Wagenius G, Brodin O, Bergqvist M. Neoplasma; 2006 Jul; 53(4):285-90. PubMed ID: 16830054 [Abstract] [Full Text] [Related]
37. Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control. Hsu IL, Su WC, Yan JJ, Chang JM, Lai WW. Lung Cancer; 2009 Sep; 65(3):371-6. PubMed ID: 19157636 [Abstract] [Full Text] [Related]
38. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA. Saito T, Kobayashi M, Harada R, Uemura Y, Taguchi H. Cancer; 2003 May 15; 97(10):2504-11. PubMed ID: 12733150 [Abstract] [Full Text] [Related]
39. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma. Poon RT, Lau CP, Cheung ST, Yu WC, Fan ST. Cancer Res; 2003 Jun 15; 63(12):3121-6. PubMed ID: 12810638 [Abstract] [Full Text] [Related]
40. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma. Kojima H, Shijubo N, Yamada G, Ichimiya S, Abe S, Satoh M, Sato N. Cancer; 2005 Oct 15; 104(8):1668-77. PubMed ID: 16116610 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]